These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 505369)

  • 1. Inhibition of spontaneous platelet aggregation by sulfinpyrazone.
    Nenci GG; Agnelli G; Berrettini M; Parise P; Ballatori E
    Thromb Haemost; 1979 Aug; 42(2):621-5. PubMed ID: 505369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
    The Canadian Cooperative Stroke Study Group
    Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet aggregation and atherosclerosis.
    Valladares BK; Lemberg L
    Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
    Latour JG; Theroux P; Bourassa MG
    Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Personal experience with the administration of sulfinpyrazone to patients with kidney failure].
    Opatrný K; Cepelák V; Opatrný K; Valenta J; Cepeláková H; Sefrna F
    Vnitr Lek; 1986 Jul; 32(7):673-80. PubMed ID: 3526712
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spontaneous thrombocyte aggregation in patients with ischemic cardiopathy. Effect of anti-aggregant treatment on thrombocyte function and other coagulation factors].
    Niţă I; Papilian M; Theodorini S; Stroescu V
    Med Interne; 1984; 22(2):113-22. PubMed ID: 6740182
    [No Abstract]   [Full Text] [Related]  

  • 11. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
    Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
    Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with sulfinpyrazone of essential mixed cryoglobulinemia.
    Boschetti C; Cortellaro M; Invernizzi F; Massaro P; Rigolone A; Polli E
    Boll Ist Sieroter Milan; 1985; 64(1):55-8. PubMed ID: 3159402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfinpyrazone and platelet function in hypertensive patients.
    Davi G; Novo S; Gullotti D; Avellone G; Sofia MA; Strano A
    Thromb Haemost; 1984 Jul; 51(3):413. PubMed ID: 6388015
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of sulfinpyrazone on the platelet function and in experimental thrombosis].
    Haas S; Ketterl R; Blümel G
    Fortschr Med; 1981 Jan; 99(4):113-8. PubMed ID: 7274948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex difference in circulating platelet aggregates and response to antiplatelet treatment.
    Nenci GG; Agnelli G; Parise P; Merante F; Ballatori E
    Thromb Haemost; 1982 Dec; 48(3):341. PubMed ID: 7164022
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulphinpyrazone inhibits development of atherosclerosis in rabbits.
    Grodzińska L; Dembińska-Kieć A
    Artery; 1980; 8(5):426-30. PubMed ID: 7213049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment and prevention of thromboembolism with anti-aggregation drugs].
    Donner L
    Vnitr Lek; 1981 May; 27(5):487-95. PubMed ID: 7245635
    [No Abstract]   [Full Text] [Related]  

  • 18. The Anturane reinfarction trial.
    Sherry S
    Thromb Haemost; 1979 Feb; 41(1):197-201. PubMed ID: 483231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of retinal vein occlusions by a platelet antiaggregant: sulfinpyrazone (Anturan 200)].
    Constantinides G; Philibert P
    Bull Soc Ophtalmol Fr; 1986; 86(6-7):913-5. PubMed ID: 3829271
    [No Abstract]   [Full Text] [Related]  

  • 20. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus.
    Spohr C; Brøns C; Winther K; Dyerberg J; Vaag A
    Platelets; 2005 Aug; 16(5):301-5. PubMed ID: 16011981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.